Viimased lisandused - BRVO with NV - PRP laser 38 year old female The vision in the left eye blurred for 10 months. She has a doctor she has seen recently with insurance and now is seeking care for the eye problem. Her prior doctor closed down and it has taken some time to get plugged into the eye care.Â
Medical Hx: Diabetes Type II. Hyperlipidemia.
Systemic Meds: Metformin HCL. Cholesterol Medication. Multi-Vitamins.
VA OD: sc20/20 NscJ1+VA OS: sc20/160-1 PHNI Nsc20/800
IOP: TP: OD:16 OS:15Â
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 32438 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 31438 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 31938 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 33338 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 29438 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 28038 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 29838 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 31738 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 31838 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 30938 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 30938 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 33438 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 29938 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 32638 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 27538 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 32538 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 29938 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 28538 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 29538 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|

Branch Retinal Vein Occlusion - Foveal Ischemia Neovascularization Non perfusionvaatamisi: 28738 year old patient with a BRVO who had PRP laser for vitreous hemorrhage. Vision remained 20/160 from foveal ischemiaveebr 24, 2023
|
|
|
|
38 year old female The vision in the left eye blurred for 10 months. She has a doctor she has seen recently with insurance and now is seeking care for the eye problem. Her prior doctor closed down and it has taken some time to get plugged into the eye care.Â
Medical Hx: Diabetes Type II. Hyperlipidemia.
Systemic Meds: Metformin HCL. Cholesterol Medication. Multi-Vitamins.
VA OD: sc20/20 NscJ1+VA OS: sc20/160-1 PHNI Nsc20/800
IOP: TP: OD:16 OS:15Â